Want to join the conversation?
$MRK 2Q15 Call: Last month, the FDA accepted the supplemental BLA for KEYTRUDA, an advanced non-small cell lung cancer, and granted KEYTRUDA Priority Review. This past week, the European Commission approved KEYTRUDA for the treatment of advanced melanoma in adults, both as a first line therapy and in previously treated patients.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.